Pharmaceutical Investing 2022

Pharmaceutical Investing

LYNPARZA® in Combination With Abiraterone and Prednisone or Prednisolone Receives Positive Opinion From EU CHMP as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer

Markets
TSX	20383.77	+39.70
TSXV	575.64	-5.68
DOW	34347.03	+152.97
S&P 500	4026.12	-1.14
NASD	11226.36	-58.96
ASX	7259.50	+17.70

Markets

TSX

20383.77

+39.70

TSXV

575.64

-5.68

DOW

34347.03

+152.97

S&P 500

4026.12

-1.14

NASD

11226.36

-58.96

ASX

7259.50

+17.70

Commodities
Gold	1754.60	+1.00
Silver	21.61	+0.03
Copper	3.63	+0.01
Palladium	1856.61	+10.62
Platinum	984.00	+3.00
Oil	76.55	-1.39
Heating Oil	3.21	-0.07
Natural Gas	6.80	-0.51

Commodities

Gold

1754.60

+1.00

Silver

21.61

+0.03

Copper

3.63

+0.01

Palladium

1856.61

+10.62

Platinum

984.00

+3.00

Oil

76.55

-1.39

Heating Oil

3.21

-0.07

Natural Gas

6.80

-0.51

Silver Viper Minerals Announces $2 Million Private Placement

Investing News NetworkYour trusted source for investing success

pharmaceutical investing 2022

Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial

Merck Announces Phase 3 KEYNOTE-859 Trial Met Primary Endpoint of Overall Survival in Patients With HER2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma

Merck to Present at the 5th Annual Evercore ISI HealthCONx Conference

Merck to Acquire Imago BioSciences, Inc.

Albert Labs signs Letter of Intent with iNGEN? CRO for First In-Human Clinical Studies

LYNPARZA® in Combination With Abiraterone and Prednisone or Prednisolone Receives Positive Opinion From EU CHMP as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer

How to Invest in Pharmaceutical Companies (Updated 2022)

Reductions in Certain Types of HPV-Related Cervical and Non-Cervical Diseases in Women and Men Observed with Real-World Use of Merck's GARDASIL® in Systematic Literature Review of 138 Studies

Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine

Jamieson Wellness Inc. Reports Third Quarter 2022 Financial Results

Jamieson Wellness Inc. to Accelerate Growth with Strategic Acquisition in China

Pfizer's Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma

MARKETS

COMMODITIES

DOWNLOAD FREE REPORTS

Updated! Download Your FREE 2022 Energy Outlook Report.

NEW! Download Your 2022 Oil & Gas Outlook Report.

NEW! Download Your 2022 Industrial Metals Outlook Report.

Free! Download Your FREE 2022 Base Metals Outlook Report [Updated Nov 3]

NEW! Download Your FREE 2022 Diamond Outlook Report

NEW! Download Our FREE 2022 Gaming Outlook Report. [Updated Aug 12]

FREE 2022 Blockchain Investor Report [Updated Aug 5]

Gold vs Bitcoin – Dogfight or Detente?

Start Here – Investing in Cleantech

Biotech Investing: Top Biotech ETFS, Stocks, Future Prospects

NEW! Download Your FREE 2022 Pharmaceuticals Outlook Report.

FREE 2022 Psychedelics Investor Report [Updated Aug 5]

Start Here – Investing in Pharma

Start Here – Investing in Genetics

BROWSE COMPANIES BY SECTOR

Featured Stocks

Bold Ventures

Slave Lake Zinc

Ultra Lithium

Redstone Resources

Infinity Stone Ventures

Optimum Ventures